Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-15
DOI
10.1038/s41598-020-80010-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps
- (2020) Betsy J. Barnes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fibrinolysis Shutdown Correlates to Thromboembolic Events in Severe COVID-19 Infection
- (2020) Franklin L. Wright et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
- (2020) Claire S Whyte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae
- (2020) Hau C. Kwaan SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
- (2020) Sharon E Fox et al. Lancet Respiratory Medicine
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
- (2020) Hanny Al-Samkari et al. BLOOD
- Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome
- (2020) Elizabeth A Middleton et al. BLOOD
- COVID-19 and pneumonia: a role for the uPA/uPAR system
- (2020) Daniele D’Alonzo et al. DRUG DISCOVERY TODAY
- Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis
- (2020) Florian Langer et al. Hamostaseologie
- Fibrinolysis and COVID‐19: A plasmin paradox
- (2020) Robert L. Medcalf et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
- (2020) Annabel Blasi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis
- (2020) Christophe Nougier et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Fibrinolysis Shutdown and Thrombosis in A COVID-19 ICU
- (2020) Christina Creel-Bulos et al. SHOCK
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- Neutrophil extracellular traps in COVID-19
- (2020) Yu Zuo et al. JCI Insight
- Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
- (2020) Panagiotis Skendros et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
- (2019) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The S100A10 Pathway Mediates an Occult Hyperfibrinolytic Subtype in Trauma Patients
- (2018) Lewis S. Gall et al. ANNALS OF SURGERY
- Upregulation of P2Y2R, Active uPA, and PAI-1 Are Essential Components of Hantavirus Cardiopulmonary Syndrome
- (2018) Virginie Bondu et al. Frontiers in Cellular and Infection Microbiology
- Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
- (2018) Cong Liu et al. Frontiers in Immunology
- Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in SepsisSignificance
- (2015) Travis J. Gould et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Basic mechanisms and regulation of fibrinolysis
- (2015) C. Longstaff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Nebulized Fibrinolytic Agents Improve Pulmonary Fibrinolysis but Not Inflammation in Rat Models of Direct and Indirect Acute Lung Injury
- (2013) Jorrit J. Hofstra et al. PLoS One
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
- (2013) L. E. Gralinski et al. mBio
- The incidence and magnitude of fibrinolytic activation in trauma patients
- (2012) I. RAZA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice
- (2011) A. J. Courey et al. BLOOD
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
- (2010) M. E. Meltzer et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started